University of Edinburgh-Roslin Institute, UK
Professor of Skeletal Biology within the Royal (Dick) School of Veterinary Studies. His research is focused on the fundamental cellular mechanisms underpinning bone and cartilage growth, development and function. Of particular interest is the GH-IGF-1 axis and its effects on bone formation and endochondral growth and how disease states e.g. chronic kidney disease, muscular dystrophy and inflammatory bowel disease impact on bone development and turnover. The mechanisms of skeletal mineralisation and in particular the role of phosphatases are also an ongoing research interest.
Charles University, Czech Republic
Professor of Internal Medicine at the Charles University, Prague; Head of Diabetes Centre and Head of the Laboratory of Translational and Experimental Diabetology and Obesitology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. His major research focus is on the etiopathogenesis of obesity, insulin resistance and type 2 diabetes mellitus with special interest in endocrine function of adipose tissue, incretin system and novel hormonal factors involved in the regulation of energy homeostasis and glucose metabolism.
Baker HDI, Australia
Associate Professor Morag Young is a leading authority on the role of hormones in cardiovascular disease, with a particular focus on mineralocorticoid receptor (MR) pathophysiology. This includes the study of the heart’s circadian clock and how disrupted circadian rhythms, and activation of the MR could damage our hearts. More broadly, she is interested in the intersection between cardiovascular disease and endocrinology, and how cellular mechanisms lead to cardiac fibrosis and inflammation, and ultimately, heart failure. Morag heads the Cardiovascular Endocrinology laboratory at the Institute. She is also a supervisor at Monash, La Trobe and Deakin Universities, and the University of Melbourne. Her discovery research program has identified novel mechanisms of MR action in cardiovascular disease that include cell-selective pathways in macrophages, cardiomyocytes and endothelial cells. Most recently, her work has identified a highly novel interaction of the MR with the molecular clock in the pathogenesis of cardiovascular disease
The First Affiliated Hospital of Sun Yat-sen University, China
Professor Xiao is current President of the First Affiliated Hospital of Sun Yat-sen University, and holds numerous society positions including Presidency of Guangdong Endocrine and Metabolism Association in the Chinese Medical Doctor Association. Professor Xiao takes the lead in treating Graves’ diseases by introducing thyroid arterial embolization, and reported relevant findings of using innovative methods to treat Graves’ diseases. His research interests have focused mainly on thyroid disease and β-cell function of diabetes.
|B J Clark
University of Louisville School of Medicine, USA
Associate Professor of Biochemistry and Molecular Genetics at the University of Louisville, Louisville, Kentucky. Her research interests focus on defining the functions of the lipid transporters STARD1 in steroidogenesis, and STARD4 and STARD5 in cholesterol and bile acid homeostasis in normal and disease states; eg diabetic nephropathy, NAFLD and cholestasis.
University of Buenos Aires, Argentina
Currently Head of the Department of Biochemistry, School of Medicine University of Buenos Aires and Director of the Biomedical Research Institute belongs to the Argentinean National Research Council. His research interests have centred on the role of intramitochondrial arachidonic acid and its metabolites in physiology (regulation of steroidogenesis) and pathology (breast cancer).
Augusta University, USA
Professor of Physiology and the Director of the Office of Postdoctoral Affairs at the Medical College of Georgia (MCG) at Augusta University. After earning her PhD in Cellular and Molecular Physiology at Yale University and performing an industrial postdoctoral fellowship at Hoffman-La Roche. Dr Bollag embarked on an academic career at MCG, where she rose through the ranks. Dr Bollag’s research interests relate to signal transduction and she has applied her expertise in cell signaling to a variety of systems, including the regulation of aldosterone production, of bone formation and of skin function.
University of Edinburgh, UK
Professor of Molecular Endocrinology in the Centre for Cardiovascular Science at the University of Edinburgh and an Adjunct Professor at the University of Western Australia. Professor Chapman’s research focuses on the actions of glucocorticoids, in immunity and inflammation and in fetal maturation. Her current research is focused on the role of glucocorticoids in maturation of the fetal and neonatal cardiovascular system and the consequences for the adult cardiovascular system. Professor Chapman is a long-standing member of the Society for Endocrinology and previously served as the General Secretary of the Society. She is a keen advocate of mentoring, postgraduate education and equality, diversity and inclusion.
University of Angers, France
Associate Professor of Histology, Embryology and Cytogenetics, University of Angers, France; Head, Bone Pathology Unit, Angers University Hospital, France; Head, Angers REGOS team – Inserm UMR_S 1229 Regenerative Medicine and Skeleton. His major research focus is understanding how bone extracellular material properties control bone strength with a special interest for the gut–bone axis.
University of Dundee, UK
Dr Cantley’s research is focused on the mechanisms that control insulin and glucagon secretion from the pancreas to maintain glucose homeostasis. Of particular interest are how these mechanisms coordinate the pancreatic endocrine response with whole body metabolic status, how they adapt during obesity, and how they fail during diabetes. Dr Cantley is a Senior Lecturer and PI at the University of Dundee, and was previously a group leader and Diabetes UK RD Lawrence Fellow at the University of Oxford.
McMaster University, Canada
Associate Professor in the Department of Biochemistry and Biomedical Sciences at McMaster University in Hamilton. Dr Schertzer holds a Canada Research Chair in Metabolic Inflammation and his research interests are focussed on understanding how xenobiotics, diet and microbial stress promote or combat obesity, prediabetes, and diabetic complications. Dr Schertzer is excited to guide scientists to discover new aspects in the connections between host glucose and commensal and pathogenic bacteria. He has a long-standing interest in endocrine control of metabolism and energy partitioning in muscle and adipose tissue.
Yale University, USA
Professor of Comparative Medicine and of Cellular & Molecular Physiology at Yale University School of Medicine. Professor Yang has pioneered the discovery of functions of protein posttranslational modifications in nutrient sensing, cell signalling and metabolic physiology. His laboratory currently studies how protein glycosylation senses nutritional and hormonal cues and mediates inter-organ communication, and how its dysregulation fuels obesity and type 2 diabetes. Professor Yang is devoted to training and mentoring the next generation of scientists. He is the past president of Chinese American Diabetes Association and the past vice president of Sino-American Pharmaceutical Professionals Association.
University of Washington, USA
Research Associate Professor in the Division of Metabolism, Endocrinology and Nutrition at the University of Washington’s Department of Medicine. Her research interest is in islet biology, where the focus is on identifying factors that regulate insulin secretion and may be targeted for therapeutic intervention in diabetes. This includes an integrated physiology approach to understanding the impact of intra-islet paracrine signaling, as well as signaling from the liver and gut on insulin secretion and glucose homeostasis. She is also Director of the Metabolic and Cellular Phenotyping Core within the University of Washington’s Diabetes Research Center.
Imperial College London, UK
Professor of molecular endocrine oncology at Imperial College London. He leads a research group investigating the mechanisms of gene regulation by nuclear receptor transcription factors, with particular focus on estrogen and androgen receptor action in breast and prostate cancer, respectively, and treatment failure. His interests include genomic profiling, new target identification and development of drugs targeting transcriptional processes in cancer.
|R M Luque
University of Córdoba, Spain
Professor of Cell Biology at the Department of Cell Biology, Physiology and Immunology of the University of Córdoba, and Head of the OncObesity and Metabolism Research Group, Maimonides Institute for Biomedical Research of Córdoba, Spain. His research focuses on the regulation of pituitary cells by neuropeptides (e.g. somatostatin, GHRH, ghrelin), and on the molecular biology and functional relevance of these and other neuropeptides, their receptors and cellular machineries (e.g. spliceosome, RNA-exosome) on pituitary adenomas and hormone-related cancers.
University of Coimbra, Portugal
Dr Carvalho is Principle Investigator at the Centre for Neuroscience and Cell Biology (CNC) at the University of Coimbra, and leads the group that studies obesity, diabetes and complications. She is currently investigating insulin action and metabolic dysfunction in adipocytes in response to in vivo treatments with immunosuppressive and antipsychotic drugs. Dr Carvalho is interested in investigating systemic and local factors that are altered in obesity and diabetes and identify dysfunctional pathways, including insulin signalling, mitochondrial function, oxidative stress and inflammation in cells and tissues, including epicardial fat in subjects with heart failure with diabetes.
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Czech Republic
Senior research group leader at Institute of Organic Chemistry and Biochemistry, Prague and PhD supervisor on Biochemistry and Pathobiochemistry PhD program at Charles University. Her research interests include the structure-activity study of peptide hormones and their analogs, the study of metabolic changes in mouse and rat models of obesity, type 2 diabetes and cardiovascular disturbances, and the study of the relationship between obesity, type 2 diabetes and Alzheimers-like pathology in mouse models of neurodegeneration.
|C García Cáceres
Helmholtz Zentrum Munchen, Germany
Lead of the the Astrocyte-Neuron Network Division, and Deputy Director at the Institute for Diabetes and Obesity (HMGU, Munich, Germany). Her research interests lie in the identification of key astrocytic signaling and molecular pathways implicated in the progression of obesity, thus inspiring and redefining therapeutic strategies to fight diabetes and obesity.
|C S Rosenfeld
University of Missouri, USA
Cheryl S Rosenfeld is a Professor of Biomedical Sciences, a Research Faculty member of the Thompson Center for Autism and Neurobehavioral Disorders, MU Institute for Data Science and Informatics (MU IDSI), and Genetics Area Program. She is currently President of the United State Developmental Origins of Health and Disease (DOHaD) Society. In 2021, she was elected as an American Association for the Advancement of Sciences (AAAS) Fellow in Medical Sciences. Her research interests focus on the placenta, neurobehavioral disorders, endocrine disrupting chemicals, and developmental origins of health and disease. She can be followed on her Twitter feed @cs_rosenfeld.
|S J Tsai
National Cheng Kung University, Taiwan
Chair Professor at the Department of Physiology, College of Medicine, National Cheng Kung University. Professor Tsai’s research interests focus on elucidating mechanisms of hypoxia-mediated drug resistance in cancer and molecular pathophysiology of gynaecological diseases such as polycystic ovarian syndrome and endometriosis.
|Steroid and Steroidogenesis|
University of Wisconsin, USA
Professor of Obstetrics & Gynecology at University of Wisconsin. Research focuses on control of pregnancy-induced changes in endothelial cell state/function/endocrine signaling particularly in uterine artery endothelium, and the role of growth factor vs cytokines in its failure in high-risk pregnancy. Control of adrenal zonation and function by Angiotensin II and integration of adrenal and gonadal steroidogenesis in higher mammals/humans. Gestational development of zonation and function of fetal adrenal gland in sheep and humans. Control of adrenal and gonadal steroidogenesis at the level of P450c17 vs 3BHSD expression and 17 alpha-hydroxylase vs lyase activity.
University of Amsterdam, the Netherlands
Anita Boelen, PhD, is a Professor of Thyroid Hormone Metabolism, in particular molecular and diagnostic aspects, in the Endocrine Laboratory at the Amsterdam University Medical Center, University of Amsterdam. She is a basic scientist with a research focus on thyroid hormone metabolism in innate immune cells and on mechanisms involved in congenital central hypothyroidism. She is in charge of the regional Dutch Neonatal Screening program at the Endocrine Laboratory in the same institution and a former member of the board of the European Thyroid Association (ETA).
Centre National de la Recherche Scientifique (CNRS), Paris, France
Head of the joint research unit Molecular Physiology and Adaption, affiliated to the Centre National de la Recherche Scientifique (CNRS) and the National Museum of Natural History of Paris. Dr Sachs’s research interests focus on the functions and mechanisms of action of thyroid hormones to understand physiological regulations that control development, tissue homeostasis, regeneration and aging in normal and altered conditions. Recently, his work has focused on the evolution of the hormonal control of life cycle transition with a special emphasis on amphibian metamorphosis and the crosstalk between thyroid hormone and glucocorticoid signalling.
|EARLY CAREER EDITORS|
King’s College Hospital, London, UK
Dr Dimitriadis is a Consultant and Senior Lecturer in Endocrinology and Obesity Medicine, Department of Endocrinology ASO/EASO COM, King’s College Hospital and also the Obesity T2DM and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences and Medicine, King’s College London, UK. His research studies the effects of medical, endoscopic and surgical interventions for the management of obesity and other dysmetabolic states (prediabetes, PCOS, NAFLD.NASH) in humans and rat models.
University of Coventry, UK
Dr Turner is an Assistant Professor in Endocrinology and Metabolism in the Centre for Sport, Exercise and Life Sciences at Coventry University. His research interests are in the impact of obesity, type 2 diabetes and non-alcoholic fatty liver disease on glucose and lipid metabolism in skeletal muscle, liver and adipose tissue and how lifestyle can contribute to the development and management of these diseases. Dr Turner completed his PhD at Loughborough University in 2015, and more recently is the recipient of the Society for Endocrinology Leadership and Development Award.
University of Birmingham, UK
Dr Sarah Berhane is a research fellow in medical statistics working in the Institute of Applied Health Research at the University of Birmingham. Her main research interests are diagnostic and prognostic modelling for the purpose of clinical prediction. She also works on projects related to systematic reviews of diagnostic test accuracy.
Ohio State University, USA
Dr Brock is an Associate Professor in the Department of Biomedical Informatics, The Ohio State University College of Medicine (OSU-COM). He serves as Associate Director of the Center for Biostatistics, Director of the Biostatistics Resource at Nationwide Children’s Hospital (BRANCH), and Director of the Biostatistics, Epidemiology, and Research Design (BERD) Core of the Center for Clinical Translational Science (CCTS). He currently serves as the lead biostatistician on multiple ongoing clinical trials, ranging from early phase studies to community-based pragmatic interventions incorporating both efficacy and implementation outcomes.
|M J Campbell
Ohio State University, USA
Professor Campbell is a Professor of Oncology at The Ohio State University. His research aims to understand how disruptions to the epigenome can act as disease-drivers in hormone responsive cancers, with the goal to exploit this understanding in either diagnostic or therapeutic settings. In 2010, Professor Campbell completed a masters in Bioinformatics at Johns Hopkins University, and since then has developed strong expertise in the analyses and integration of genomic and epigenomic data sets, and their integration with publicly available data to annotate experimental findings. Specifically, his research leverages ChIP-Seq, RNA-Seq (including splice aware), proteomics such as RIME, and other NGS approaches to study non-coding: coding RNA interactions and RNA modifications.
D Bechtold, UK
F Beier, Canada
M Björnholm, Sweden
M Caprio, Italy
J Carroll, UK
H Choi, Republic of Korea
A Erson-Bensan, Turkey
B Fam, Australia
M Fex, Sweden
C Fletcher, UK
C Gorvin, UK
D Heery, USA
H Heuer, Germany
M Huising, USA
S Jonker, USA
R O Karlstrom, USA
S Mader, Canada
Z Michailidou, UK
T Mitić, UK
J Mueller, UK
O Nilsson, Sweden
L Orbán, Singapore
P Rozance, USA
B Soria, Spain
K Staines, UK
C Too, Canada
W E Visser, Netherlands
L Weinstein, USA
Q Winger, USA
J Wolfe-Müller, UK
Q Zhai, China
Editors' declarations are listed in the journal's Disclosure Policy